Literature DB >> 22162414

Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus.

Laura J Julian1, Jinoos Yazdany, Laura Trupin, Lindsey A Criswell, Edward Yelin, Patricia P Katz.   

Abstract

OBJECTIVE: To determine the validity of standardized screening assessments of cognitive functioning to detect neuropsychological impairment evaluated using a comprehensive battery in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
METHODS: This is a cross-sectional study using a combined cohort of 139 persons with SLE and 82 persons with RA. Screening cut points were empirically derived using receiver operating characteristic curves and threshold selection methods. Screening measures included the Hopkins Verbal Learning Test-Revised (HVLT-R) learning and delayed recall indices and phonemic fluency, a composite measure of the 3 cognitive screening tests, and the Perceived Deficits Questionnaire-Short Form (PDQ-SF), a self-report measure of cognitive symptoms. A comprehensive neuropsychological battery was administered as the "gold standard" index of neuropsychological impairment.
RESULTS: Rates of neuropsychological impairment were 27% and 15% for the SLE and RA cohorts, respectively. Optimal threshold estimations were derived for 5 screening techniques. The HVLT-R learning and phonemic fluency indices yielded the greatest sensitivity at 81%. The PDQ-SF yielded the lowest sensitivity at 52%. All measures were significantly associated with neuropsychological impairment after controlling for relevant sociodemographic covariates and depression.
CONCLUSION: These results suggest that telephone-administered screening techniques may be useful measures to identify persons with neuropsychological impairment. Specifically, measures of phonemic fluency and verbal learning appeared to be most sensitive and least likely to misclassify impaired individuals as cognitively intact. Self-reported questionnaires may have relatively decreased sensitivity compared to standardized interviewer-administered cognitive measures.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 22162414      PMCID: PMC3705711          DOI: 10.1002/acr.21566

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  14 in total

1.  "Subcortical" cognitive impairment in patients with systemic lupus erythematosus.

Authors:  E Leritz; J Brandt; M Minor; F Reis-Jensen; M Petri
Journal:  J Int Neuropsychol Soc       Date:  2000-11       Impact factor: 2.892

2.  Odd-even short forms of the Judgment of Line Orientation Test.

Authors:  R D Venderploeg; L V LaLone; P Greblo; J A Schinka
Journal:  Appl Neuropsychol       Date:  1997

Review 3.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors: 
Journal:  Arthritis Rheum       Date:  1999-04

4.  Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis.

Authors:  Ruth Ann Marrie; Gordon J Chelune; Deborah M Miller; Jeffrey A Cohen
Journal:  Mult Scler       Date:  2005-02       Impact factor: 6.312

5.  Work dynamics among persons with systemic lupus erythematosus.

Authors:  Edward Yelin; Laura Trupin; Patricia Katz; Lindsey Criswell; Jinoos Yazdany; Joann Gillis; Peter Panopalis
Journal:  Arthritis Rheum       Date:  2007-02-15

6.  The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis.

Authors:  L Julian; N M Merluzzi; D C Mohr
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

7.  Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.

Authors:  B A Parmenter; B Weinstock-Guttman; N Garg; F Munschauer; R H B Benedict
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

8.  Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study.

Authors:  M Bartolini; M Candela; M Brugni; L Catena; F Mari; G Pomponio; L Provinciali; G Danieli
Journal:  Clin Exp Rheumatol       Date:  2002 Jul-Aug       Impact factor: 4.473

Review 9.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

10.  Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus.

Authors:  Elizabeth Kozora; Misoo C Ellison; Sterling West
Journal:  Arthritis Rheum       Date:  2004-10-15
View more
  10 in total

1.  A Prospective Study of the Impact of Current Poverty, History of Poverty, and Exiting Poverty on Accumulation of Disease Damage in Systemic Lupus Erythematosus.

Authors:  Edward Yelin; Laura Trupin; Jinoos Yazdany
Journal:  Arthritis Rheumatol       Date:  2017-07-05       Impact factor: 10.995

2.  Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus.

Authors:  Sara G Murray; Jinoos Yazdany; Rachel Kaiser; Lindsey A Criswell; Laura Trupin; Edward H Yelin; Patricia P Katz; Laura J Julian
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-09       Impact factor: 4.794

3.  Preliminary Findings from a Telephone-Based Cognitive Screening of an Adult HIV Research Cohort during the COVID-19 Pandemic.

Authors:  Jairo A Gonzalez; Uraina S Clark; Desiree Byrd; Yusuf Clarke; Kaitlyn Greenwood; Elizabeth Tell; Cira Carrion-Park; Maria Pizzirusso; Rhonda Burgess; Susan Morgello
Journal:  Arch Clin Neuropsychol       Date:  2022-07-02       Impact factor: 3.448

4.  A Computerized Assessment of Verbal and Visuospatial Memory (Dys)functions in Patients with Rheumatoid Arthritis.

Authors:  Cristian Vasile Petra; Laura Visu-Petra; Monica Buta; Maria Magdalena Tămaș; Oana Benga; Simona Rednic
Journal:  Psychol Res Behav Manag       Date:  2020-08-04

Review 5.  Diagnosis and management of neuropsychiatric SLE.

Authors:  John G Hanly
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

6.  Cognitive Function Trajectories in Association With the Depressive Symptoms Trajectories in Systemic Lupus Erythematosus Over Time.

Authors:  Zahi Touma; Bahar Moghaddam; Jiandong Su; Patricia Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-09-02       Impact factor: 5.178

Review 7.  Endothelial Dysfunction and Extra-Articular Neurological Manifestations in Rheumatoid Arthritis.

Authors:  Jessica Maiuolo; Carolina Muscoli; Micaela Gliozzi; Vincenzo Musolino; Cristina Carresi; Sara Paone; Sara Ilari; Rocco Mollace; Ernesto Palma; Vincenzo Mollace
Journal:  Biomolecules       Date:  2021-01-10

8.  Development, deployment and evaluation of digitally enabled, remote, supported rehabilitation for people with long COVID-19 (Living With COVID-19 Recovery): protocol for a mixed-methods study.

Authors:  Elizabeth Murray; Henry Goodfellow; Julia Bindman; Ann Blandford; Katherine Bradbury; Tahreem Chaudhry; Delmiro Fernandez-Reyes; Manuel Gomes; Fiona L Hamilton; Melissa Heightman; William Henley; John R Hurst; Hannah Hylton; Stuart Linke; Paul Pfeffer; William Ricketts; Chris Robson; Richa Singh; Fiona A Stevenson; Sarah Walker; Jonathan Waywell
Journal:  BMJ Open       Date:  2022-02-07       Impact factor: 2.692

Review 9.  Cognitive Assessment via Telephone: A Scoping Review of Instruments.

Authors:  Anne R Carlew; Hudaisa Fatima; Julia R Livingstone; Caitlin Reese; Laura Lacritz; Cody Pendergrass; Kenneth Chase Bailey; Chase Presley; Ben Mokhtari; Colin Munro Cullum
Journal:  Arch Clin Neuropsychol       Date:  2020-11-19       Impact factor: 2.813

10.  Patient Satisfaction with Telephone Neuropsychological Assessment.

Authors:  Laura H Lacritz; Anne R Carlew; Julia Livingstone; K Chase Bailey; Allison Parker; Aislinn Diaz
Journal:  Arch Clin Neuropsychol       Date:  2020-11-19       Impact factor: 2.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.